Tonix Pharmaceuticals Holding Corp Cash Flow-to-Debt Ratio
Tonix Pharmaceuticals Holding Corp cash flow-to-debt ratio. Tonix Pharmaceuticals Holding Corp (TNXP) has a Cash Flow-to-Debt Ratio of -1.24x as of December 2025, meaning its operating cash flow of $-39.65 Million could theoretically repay -1% of its total liabilities ($32.02 Million) in one year. See TNXP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tonix Pharmaceuticals Holding Corp (2008–2025)
Cash flow-to-debt ratio of Tonix Pharmaceuticals Holding Corp from 2008 to 2025. Historical debt coverage capacity for Tonix Pharmaceuticals Holding Corp across 18 annual periods. Also explore TNXP year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tonix Pharmaceuticals Holding Corp Cash Flow-to-Debt Ratio by Year (2008–2025)
Tonix Pharmaceuticals Holding Corp cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Tonix Pharmaceuticals Holding Corp. For the full cash flow conversion analysis, see Tonix Pharmaceuticals Holding Corp cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.12x | $-99.84 Million | $32.02 Million | ▼ -19.4% |
| 2024 | -2.61x | $-60.92 Million | $23.33 Million | ▼ -25.3% |
| 2023 | -2.08x | $-102.00 Million | $48.93 Million | ▲ +60.7% |
| 2022 | -5.30x | $-98.05 Million | $18.51 Million | ▼ -55.5% |
| 2021 | -3.41x | $-75.56 Million | $22.18 Million | ▲ +26.1% |
| 2020 | -4.61x | $-48.57 Million | $10.54 Million | ▲ +11.2% |
| 2019 | -5.19x | $-26.68 Million | $5.14 Million | ▲ +42.5% |
| 2018 | -9.03x | $-23.97 Million | $2.65 Million | ▼ -0.9% |
| 2017 | -8.95x | $-19.13 Million | $2.14 Million | ▲ +48.5% |
| 2016 | -17.36x | $-37.31 Million | $2.15 Million | ▼ -175.8% |
| 2015 | -6.29x | $-42.53 Million | $6.76 Million | ▲ +4.9% |
| 2014 | -6.62x | $-22.84 Million | $3.45 Million | ▼ -72.9% |
| 2013 | -3.83x | $-8.52 Million | $2.22 Million | ▲ +22.3% |
| 2012 | -4.93x | $-5.71 Million | $1.16 Million | ▼ -438.3% |
| 2011 | -0.92x | $-2.64 Million | $2.88 Million | ▲ +47.5% |
| 2010 | -1.74x | $-17.98K | $10.30K | ▲ +93.8% |
| 2009 | -28.21x | $-27.87K | $988.00 | ▼ -259.1% |
| 2008 | -7.86x | $-23.57K | $3.00K | — |